
KRAS - Wikipedia
KRAS (Kirsten rat sarcoma virus) is a gene that provides instructions for making a protein called K-Ras, a part of the RAS/MAPK pathway. The protein relays signals from outside the cell to …
The current understanding of KRAS protein structure and dynamics
GTPase KRas (KRAS) is a signal transducer protein, which plays an important role in various cellular signalling events such as in regulation of cell proliferation.
KRAS mutation: from undruggable to druggable in cancer
Nov 15, 2021 · As the most frequently mutated oncogene, Kirsten rat sarcoma viral oncogene homologue (KRAS) has attracted substantial attention. The understanding of KRAS is …
KRAS gene - MedlinePlus
The KRAS gene provides instructions for making a protein called K-Ras that is part of a signaling pathway known as the RAS/MAPK pathway. Learn about this gene and related health conditions.
Targeting KRAS in cancer - Nature Medicine
Apr 18, 2024 · Herein, we outline RAS pathobiology with a focus on KRAS, illustrate therapeutic approaches across a variety of malignancies, including emphasis on the ‘on’ and ‘off’ switch …
Oncogenic KRAS: Signaling and Drug Resistance - PMC
KRAS is one of the Ras superfamily isoforms (N-RAS, H-RAS, and K-RAS) that frequently mutate in cancer. The mutation of KRAS is essentially performing the transformation in humans. Since …
What’s new in KRAS mutation research? - MD Anderson Cancer Center
Apr 4, 2024 · The most frequently mutated of these oncogenic driver genes, called KRAS, is associated with some of the most fatal cancer types: lung, pancreatic and colorectal cancers.
KRAS: From undruggable to a druggable Cancer Target
K-RAS is the most commonly mutated RAS isoform. The Ras protein is a membrane bound protein with inherent GTPase activity and is activated by numerous extracellular stimuli, …
Understand KRAS and the Quest for Anti-Cancer Drugs - PMC
KRAS is inactivated by GAPs, such as neurofibromatosis type 1 (NF1), Ras protein activator like -1 or -2 (RASAL1 or 2), and disabled homolog 2-interaction protein (DAB2IP). KRAS has weak …
KRAS - Know Your Biomarker
All patients with stage IV / metastatic colorectal cancer should have KRAS biomarker testing. KRAS is a gene involved in controlling cell growth and cell survival. 40% of colorectal cancers …